NEOGEN CORP Quarterly Deferred Income Tax Expense (Benefit) in USD from Q3 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Neogen Corp quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q3 2021 to Q3 2024.
- Neogen Corp Deferred Income Tax Expense (Benefit) for the quarter ending August 31, 2024 was -$9.12M, a 1014% decline year-over-year.
- Neogen Corp annual Deferred Income Tax Expense (Benefit) for 2023 was -$27.4M, a 42.6% decline from 2022.
- Neogen Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$19.2M, a 310% decline from 2021.
- Neogen Corp annual Deferred Income Tax Expense (Benefit) for 2021 was -$4.7M, a 634% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)